Large gap with delayed quotes
|
Last quote
12/26/2024 -
20:00:00
|
Bid
12/27/2024 -
05:48:04
|
Bid Volume |
Ask
12/27/2024 -
05:48:04
|
Ask Volume |
|---|---|---|---|---|
|
149.90
+0.88
(
+0.59% )
|
148.61
|
100 |
150.47
|
100 |
Analysis date: 24.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 11.10.2024.
Interest
None
None
No interest since 02.08.2024.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 02.08.2024 at a price of 205.66.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 26.07.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-6.99%
-6.99%
The four week relative underperformance versus SP500 is 6.99%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.76%.
Mkt Cap in $bn
21.77
21.77
With a market capitalization >$8bn, BIOGEN is considered a large-cap stock.
G/PE Ratio
0.73
0.73
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
8.56
8.56
The estimated PE is for the year 2026.
LT Growth
6.28%
6.28%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
28
28
Over the last seven weeks, an average of 28 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
48
48
For 1% of index variation, the stock varies on average by 0.48%.
Correlation
0.30
0.30
Stock movements are strongly independent of index variations.
Value at Risk
17.90
17.90
The value at risk is estimated at USD 17.90. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002